glycyrrhizic acid has been researched along with Infections, Pseudomonas in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Bessert, DA; Hazlett, LD; McClellan, SA; Pitchaikannu, A; Somayajulu, M | 1 |
| Barrett, RP; Ekanayaka, SA; Hazlett, LD; McClellan, SA | 1 |
| Ekanayaka, SA; Francis, R; Hazlett, LD; McClellan, SA | 1 |
| Hendon, DN; Kobayashi, M; Lee, JO; Nakamura, K; Suzuki, F; Suzuki, S; Yoshida, S | 1 |
| Barrett, RP; Ekanayaka, SA; Hazlett, LD; Kharotia, S; McClellan, SA | 1 |
| Herndon, DN; Kobayashi, M; Suzuki, F; Yoshida, S; Yoshida, T | 1 |
| Al-Benna, S; Jacobsen, F; Schubert, C; Steinstraesser, L | 1 |
7 other study(ies) available for glycyrrhizic acid and Infections, Pseudomonas
| Article | Year |
|---|---|
Ocular Effects of Glycyrrhizin at Acidic and Neutral pH.
Topics: Animals; Glycyrrhizic Acid; Hydrogen-Ion Concentration; Keratitis; Mice; Mice, Inbred C57BL; Pseudomonas aeruginosa; Pseudomonas Infections | 2021 |
Topical Glycyrrhizin Is Therapeutic for Pseudomonas aeruginosa Keratitis.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Female; Glycyrrhizic Acid; Keratitis; Mice; Mice, Inbred C57BL; Pseudomonas aeruginosa; Pseudomonas Infections | 2018 |
Glycyrrhizin Use for Multi-Drug Resistant Pseudomonas aeruginosa: In Vitro and In Vivo Studies.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Ciprofloxacin; Corneal Ulcer; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Glycyrrhizic Acid; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Microscopy, Confocal; Microscopy, Electron, Scanning; Pseudomonas aeruginosa; Pseudomonas Infections; Real-Time Polymerase Chain Reaction; RNA, Bacterial; RNA, Messenger | 2019 |
Effect of glycyrrhizin on pseudomonal skin infections in human-mouse chimeras.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Animals; beta-Defensins; Burns; Cells, Cultured; Child; Child, Preschool; Female; Gene Expression; Glycyrrhizic Acid; Heterografts; Humans; Leukocytes, Mononuclear; Male; Mice, Inbred NOD; Mice, SCID; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Skin; Skin Diseases, Bacterial; Skin Transplantation; Young Adult | 2014 |
Glycyrrhizin Reduces HMGB1 and Bacterial Load in Pseudomonas aeruginosa Keratitis.
Topics: Animals; Anti-Inflammatory Agents; Bacterial Load; Cornea; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Eye Infections, Bacterial; Female; Gene Expression Regulation; Glycyrrhizic Acid; HMGB1 Protein; Keratitis; Mice; Mice, Inbred C57BL; Pseudomonas aeruginosa; Pseudomonas Infections; Real-Time Polymerase Chain Reaction; RNA, Messenger | 2016 |
Pivotal advance: glycyrrhizin restores the impaired production of beta-defensins in tissues surrounding the burn area and improves the resistance of burn mice to Pseudomonas aeruginosa wound infection.
Topics: Animals; beta-Defensins; Burns; Chemokine CCL2; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Glycyrrhizic Acid; Humans; Interleukin-10; Interleukins; Keratinocytes; Male; Mice; Mice, Inbred BALB C; Pseudomonas aeruginosa; Pseudomonas Infections; T-Lymphocyte Subsets; Wound Infection | 2010 |
Editorial: glycyrrhizin against multi-resistant bacteria?
Topics: Animals; beta-Defensins; Burns; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Glycyrrhizic Acid; Humans; Immunity, Innate; Keratinocytes; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Wound Infection | 2010 |